A Study of Intravesical BCG in Combination With ALT-803 in BCG Naïve Patients with High-Grade, Non-Muscle Invasive Bladder Cancer
Acceptance Requirements
![](https://immunitybio.com/wp-content/uploads/2023/09/icon-adult-patient.png)
Adult patients diagnosed with non-muscle invasive bladder cancer (NMIBC) that is considered carcinoma in situ or high-grade papillary disease
![](https://immunitybio.com/wp-content/uploads/2023/09/icon-checkmark.png)
Must be able to walk, care for themselves and attend study-site visits